ITPA GENETIC VARIANTS ARE PROTECTIVE AGAINST ANEMIA DURING ANTIVIRAL THERAPY FOR G2/3 HCV, BUT DO NOT DECREASE THE NEED FOR RBV DOSE REDUCTION OR INCREASE SVR

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Thompson, AJ; Santoro, R; Piazzolla, V; Tillman, HL; Patel, K; Clark, PJ; Naggie, S; Shianna, K; Mottola, L; Petruzzellis, D; Romano, M; Sogari, F; Facciorusso, D; Goldstein, DB; McHutchison, JG; Mangia, A

Published Date

  • October 1, 2010

Published In

Volume / Issue

  • 52 / 4

Start / End Page

  • 785A - 786A

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0270-9139

Conference Name

  • 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases

Conference Location

  • Boston, MA

Conference Start Date

  • October 29, 2010

Conference End Date

  • November 2, 2010